ER004
EDELIFE
Phase 2 small_molecule active
Quick answer
ER004 for X-linked hypohidrotic ectodermal dysplasia (XLHED) is a Phase 2 program (small_molecule) at Pierre Fabre Medicament with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pierre Fabre Medicament
- Indication
- X-linked hypohidrotic ectodermal dysplasia (XLHED)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active